145 related articles for article (PubMed ID: 37554941)
1. A clinicopathological analysis of forkhead box A1 (FOXA1) and estrogen receptor alpha expression in extramammary Paget's disease.
Sumitomo C; Iwata Y; Arima M; Sugiura K
Fujita Med J; 2023 Aug; 9(3):236-239. PubMed ID: 37554941
[TBL] [Abstract][Full Text] [Related]
2. Frequent
Takeichi T; Okuno Y; Matsumoto T; Tsunoda N; Suzuki K; Tanahashi K; Kono M; Kikumori T; Muro Y; Akiyama M
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235312
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
Mai R; Zhou S; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Zhang G
Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
[TBL] [Abstract][Full Text] [Related]
4. Mammary and Extramammary Paget's Disease Presented Different Expression Pattern of Steroid Hormone Receptors.
Zhou S; Zhong W; Mai R; Zhang G
Biomed Res Int; 2017; 2017():3768247. PubMed ID: 29082243
[TBL] [Abstract][Full Text] [Related]
5. The expression of EpCAM in extramammary Paget's disease.
Yamada-Kanazawa S; Tasaki Y; Kajihara I; Sakamoto R; Maeda-Otsuka S; Ihn H
Intractable Rare Dis Res; 2019 Feb; 8(1):20-23. PubMed ID: 30881853
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease.
Cho Z; Konishi E; Kanemaru M; Isohisa T; Arita T; Kawai M; Tsutsumi M; Mizutani H; Takenaka H; Ozawa T; Tsuruta D; Katoh N; Asai J
J Dermatol Sci; 2017 Jul; 87(1):29-35. PubMed ID: 28381343
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and clinicopathological study regarding nardilysin on extramammary Paget's disease.
Yamaguchi A; Takahashi T; Kato T; Tanaka T; Nishi E; Fujimoto N
Arch Dermatol Res; 2023 Sep; 315(7):1979-1987. PubMed ID: 36867223
[TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth factor-1 receptor, p-AKT and p-ERK1/2 protein in extramammary Paget's disease.
Liu H; Moroi Y; Yasumoto S; Kokuba H; Imafuku S; Koga T; Masuda T; Tu Y; Furue M; Urabe K
Br J Dermatol; 2006 Sep; 155(3):586-91. PubMed ID: 16911286
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of mucin genes in mammary and extramammary Paget's disease.
Kuan SF; Montag AG; Hart J; Krausz T; Recant W
Am J Surg Pathol; 2001 Dec; 25(12):1469-77. PubMed ID: 11717535
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.
Kitamura S; Yanagi T; Maeda T; Ujiie H
Cancer Sci; 2022 Feb; 113(2):802-807. PubMed ID: 34866279
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the methods used to detect HER2-positive advanced extramammary Paget's disease.
Hirai I; Tanese K; Nakamura Y; Otsuka A; Fujisawa Y; Yamamoto Y; Hata H; Fujimura T; Matsushita S; Yoshino K; Kameyama K; Amagai M; Funakoshi T
Med Oncol; 2018 May; 35(6):92. PubMed ID: 29744813
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.
Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y
J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852
[TBL] [Abstract][Full Text] [Related]
13. Definition, Association with Malignancy, Biologic Behavior, and Treatment of Ectopic Extramammary Paget's Disease: A Review of the Literature.
Scarbrough CA; Vrable A; Carr DR
J Clin Aesthet Dermatol; 2019 Aug; 12(8):40-44. PubMed ID: 31531170
[No Abstract] [Full Text] [Related]
14. MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease.
Hata H; Abe R; Hoshina D; Saito N; Homma E; Aoyagi S; Shimizu H
J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):727-32. PubMed ID: 23581859
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease.
Azmahani A; Nakamura Y; Ozawa Y; McNamara KM; Fujimura T; Haga T; Hashimoto A; Aiba S; Sasano H
Hum Pathol; 2015 Nov; 46(11):1662-9. PubMed ID: 26359540
[TBL] [Abstract][Full Text] [Related]
16. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Uchi H; Takahara M; Uenotsuchi T; Tu YT; Urabe K; Furue M
Int J Dermatol; 2008 Jun; 47(6):562-6. PubMed ID: 18477144
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
[TBL] [Abstract][Full Text] [Related]
18. Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method.
Arita T; Kondo J; Kaneko Y; Tsutsumi M; Kanemaru M; Matsui M; Arakawa Y; Katoh N; Inoue M; Asai J
J Dermatol Sci; 2020 Sep; 99(3):185-192. PubMed ID: 32800410
[TBL] [Abstract][Full Text] [Related]
19. Primary extramammary Paget's disease: a clinicopathological study of 28 cases.
Zhao Y; Gong X; Li N; Zhu Q; Yu D; Jin X
Int J Clin Exp Pathol; 2019; 12(9):3426-3432. PubMed ID: 31934186
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of treatment options for extramammary Paget's disease: a SEER database analysis.
Ma X; Li Y
Transl Cancer Res; 2021 Jun; 10(6):2873-2881. PubMed ID: 35116597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]